294.86
USD
9.02
(3.16%)
Post Trading·295.20USD+0.34(+0.12%)
Last updated: · Delayed 15 min
Fair value398.80Plus-26%299Price 294.86499
Q4 FY2026 · Earnings report
EPS estimate 3.89Revenue estimate 18.33B
Q4 FY2026 · Earnings report
EPS estimate 3.89Revenue estimate 18.33B
ABBVIE cash on hand 2010–2026
ABBVIE had 10.77B USD in cash and short-term investments on 30 September 2026, up 90.0% on a year before. At the end of fiscal year 2025 it had 5.26B USD.
Last updated 4 Nov 2026 · Next report 3 Feb 2027
Cash on hand
Growth
| Fiscal year | Period ending | Cash on hand | Growth | Total debt | Net cash |
|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 10.77B | +89.98% | 80.90B | -70.13B |
| FY2025 | 31 Dec 2025 | 5.26B | -5.36% | 69.07B | -63.81B |
| FY2024 | 31 Dec 2024 | 5.56B | -56.66% | 67.84B | -62.29B |
| FY2023 | 31 Dec 2023 | 12.82B | +38.87% | 60.12B | -47.30B |
| FY2022 | 31 Dec 2022 | 9.23B | -6.11% | 64.19B | -54.96B |
| FY2021 | 31 Dec 2021 | 9.83B | +15.93% | 77.58B | -67.75B |
| FY2020 | 31 Dec 2020 | 8.48B | -78.76% | 87.06B | -78.58B |
| FY2019 | 31 Dec 2019 | 39.92B | +395.27% | 67.09B | -27.16B |
| FY2018 | 31 Dec 2018 | 8.06B | -17.65% | 40.31B | -32.25B |
| FY2017 | 31 Dec 2017 | 9.79B | +52.41% | 37.37B | -27.58B |
| FY2016 | 31 Dec 2016 | 6.42B | -23.60% | 36.84B | -30.42B |
| FY2015 | 31 Dec 2015 | 8.41B | +0.39% | 31.67B | -23.26B |
| FY2014 | 31 Dec 2014 | 8.37B | -15.37% | 15.01B | -6.64B |
| FY2013 | 31 Dec 2013 | 9.90B | +24.06% | 14.72B | -4.83B |
| FY2012 | 31 Dec 2012 | 7.98B | +1,121.44% | 15.67B | -7.70B |
| FY2011 | 31 Dec 2011 | 653.00M | +5,960.32% | 0.00 | 653.00M |
| FY2010 | 31 Dec 2010 | 10.78M | — | 0.00 | 10.78M |
| Quarter | Period ending | Cash on hand | Growth on a year before | Total debt | Net cash |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 10.77B | +89.98% | 80.90B | -70.13B |
| Q2 FY2026 | 30 Jun 2026 | 6.57B | +1.58% | 70.82B | -64.25B |
| Q1 FY2026 | 31 Mar 2026 | 9.39B | +81.43% | 72.86B | -63.47B |
| Q4 FY2025 | 31 Dec 2025 | 5.26B | -5.36% | 68.87B | -63.62B |
| Q3 FY2025 | 30 Sept 2025 | 5.67B | -22.16% | 68.74B | -63.07B |
| Q2 FY2025 | 30 Jun 2025 | 6.47B | -50.85% | 70.48B | -64.01B |
| Q1 FY2025 | 31 Mar 2025 | 5.18B | -71.35% | 69.89B | -64.71B |
| Q4 FY2024 | 31 Dec 2024 | 5.56B | -56.66% | 67.84B | -62.29B |
| Q3 FY2024 | 30 Sept 2024 | 7.29B | -45.18% | 71.08B | -63.79B |
| Q2 FY2024 | 30 Jun 2024 | 13.16B | +50.09% | 70.63B | -57.48B |
| Q1 FY2024 | 31 Mar 2024 | 18.07B | +168.80% | 74.00B | -55.93B |
| Q4 FY2023 | 31 Dec 2023 | 12.82B | +38.87% | 60.12B | -47.30B |
| Q3 FY2023 | 30 Sept 2023 | 13.29B | +11.88% | 60.75B | -47.46B |
| Q2 FY2023 | 30 Jun 2023 | 8.77B | -12.00% | 61.02B | -52.25B |
| Q1 FY2023 | 31 Mar 2023 | 6.72B | -11.23% | 62.09B | -55.37B |
| Q4 FY2022 | 31 Dec 2022 | 9.23B | -6.11% | 64.19B | -54.96B |
| Q3 FY2022 | 30 Sept 2022 | 11.88B | -3.02% | 69.61B | -57.73B |
| Q2 FY2022 | 30 Jun 2022 | 9.96B | +15.83% | 72.93B | -62.97B |
| Q1 FY2022 | 31 Mar 2022 | 7.57B | -22.55% | 73.47B | -65.90B |
| Q4 FY2021 | 31 Dec 2021 | 9.83B | +15.93% | 77.58B | -67.75B |
| Q3 FY2021 | 30 Sept 2021 | 12.25B | +54.08% | 80.72B | -68.47B |
| Q2 FY2021 | 30 Jun 2021 | 8.60B | +42.38% | 82.14B | -73.54B |
| Q1 FY2021 | 31 Mar 2021 | 9.78B | -76.24% | 85.53B | -75.75B |
| Q4 FY2020 | 31 Dec 2020 | 8.48B | -78.76% | 87.06B | -78.58B |
| Q3 FY2020 | 30 Sept 2020 | 7.95B | -25.34% | 87.06B | -79.11B |
| Q2 FY2020 | 30 Jun 2020 | 6.04B | +11.52% | 87.43B | -81.39B |
| Q1 FY2020 | 31 Mar 2020 | 41.14B | +686.95% | 67.05B | -25.90B |
| Q4 FY2019 | 31 Dec 2019 | 39.92B | +395.27% | 67.09B | -27.16B |
| Q3 FY2019 | 30 Sept 2019 | 10.65B | +21.21% | 38.78B | -28.13B |
| Q2 FY2019 | 30 Jun 2019 | 5.42B | +44.70% | 37.66B | -32.25B |
| Q1 FY2019 | 31 Mar 2019 | 5.23B | -44.82% | 37.56B | -32.33B |
| Q4 FY2018 | 31 Dec 2018 | 8.06B | -17.65% | 40.31B | -32.25B |
| Q3 FY2018 | 30 Sept 2018 | 8.79B | -8.05% | 40.51B | -31.72B |
| Q2 FY2018 | 30 Jun 2018 | 3.74B | -48.05% | 37.11B | -33.37B |
| Q1 FY2018 | 31 Mar 2018 | 9.47B | +51.63% | 37.29B | -27.81B |
| Q4 FY2017 | 31 Dec 2017 | 9.79B | +52.41% | 37.37B | -27.58B |
| Q3 FY2017 | 30 Sept 2017 | 9.55B | +20.18% | 37.80B | -28.24B |
| Q2 FY2017 | 30 Jun 2017 | 7.21B | -9.96% | 37.24B | -30.03B |
| Q1 FY2017 | 31 Mar 2017 | 6.25B | -27.35% | 36.95B | -30.70B |
| Q4 FY2016 | 31 Dec 2016 | 6.42B | -23.60% | 36.84B | -30.42B |
| Q3 FY2016 | 30 Sept 2016 | 7.95B | -14.04% | 37.31B | -29.36B |
| Q2 FY2016 | 30 Jun 2016 | 8.00B | -3.35% | 37.85B | -29.84B |
| Q1 FY2016 | 31 Mar 2016 | 8.60B | +8.53% | 31.91B | -23.31B |
| Q4 FY2015 | 31 Dec 2015 | 8.41B | +0.39% | 31.67B | -23.26B |
| Q3 FY2015 | 30 Sept 2015 | 9.25B | +19.68% | 32.13B | -22.88B |
| Q2 FY2015 | 30 Jun 2015 | 8.28B | -19.20% | 31.12B | -22.84B |
| Q1 FY2015 | 31 Mar 2015 | 7.92B | -12.92% | 15.27B | -7.35B |
| Q4 FY2014 | 31 Dec 2014 | 8.37B | -15.37% | 14.98B | -6.60B |
| Q3 FY2014 | 30 Sept 2014 | 7.73B | -19.47% | 14.79B | -7.06B |
| Q2 FY2014 | 30 Jun 2014 | 10.25B | +17.04% | 14.74B | -4.50B |
| Q1 FY2014 | 31 Mar 2014 | 9.10B | +21.67% | 14.41B | -5.31B |
| Q4 FY2013 | 31 Dec 2013 | 9.90B | +24.06% | 14.72B | -4.83B |
| Q3 FY2013 | 30 Sept 2013 | 9.60B | +109.26% | 14.81B | -5.21B |
| Q2 FY2013 | 30 Jun 2013 | 8.75B | +11,644.50% | 14.76B | -6.00B |
| Q1 FY2013 | 31 Mar 2013 | 7.48B | +17,296.66% | 15.04B | -7.56B |
| Q4 FY2012 | 31 Dec 2012 | 7.98B | +1,121.44% | 15.67B | -7.70B |
| Q3 FY2012 | 30 Sept 2012 | 4.59B | — | 0.00 | 4.59B |
| Q2 FY2012 | 30 Jun 2012 | 74.54M | — | 0.00 | 74.54M |
| Q1 FY2012 | 31 Mar 2012 | 42.99M | — | 0.00 | 42.99M |
| Q4 FY2011 | 31 Dec 2011 | 653.00M | — | 48.00M | 605.00M |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet
Common questions about ABBVIE's cash
Source: Financial Modeling Prep
